Company page

Bicara Therapeutics Inc.

Bicara Therapeutics Inc. is a public company traded under the ticker BCAX in the American market. The company has a market capitalization of approximately $1.82 billion. Bicara focuses on developing innovative therapies, leveraging its expertise to advance treatment options in the healthcare sector.

BCAX:NASDAQUpdated August 28, 2026
Bicara Therapeutics Inc. logo
Ticker
BCAX:NASDAQ
Asset type
Stock
Market cap
$1.55B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD